Special Announcement - Now Enrolling for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for the first of its kind FDA approved stem cell clinical trial for knee arthritis. Our clinic is now enrolling patients in this trial. Contact us at 312-475-1893 for details. Click here to learn more.

12 days ago, on a Saturday morning, I received a call from a friend of 67 years, who left a voicemail asking me to call him. We had first met while playing 16-inch softball against each other on Chicago Park District softball diamonds. Last night, at 10:20 pm, his wife called to tell me that he had died.

He typically called every Saturday morning around 7:45 am to check in; however, this time when he had called, it was to tell me that he was being admitted to a hospital with shortness of breath. Fast forward, over the ensuing days he was given supplementary Oxygen when he was in need and he initially responded. Subsequently, the diagnosis of COVID-19 Pneumonia came with an ever-increasing need for Oxygen supplementation. Three days ago, he was placed on a respirator.

Shortly thereafter, I contacted Personalized Stem Cells Inc. (PSC) for whom I serve as a Stem Cell co-investigator for arthritis. PSC connected me to the Medical Director of Sorrento Therapeutics, a group currently involved in a Stem Cell Trial for COVID-19 Pneumonia in a San Diego Hospital. Sorrrento Therapeutics’ Medical Director volunteered to seek emergency use authorization from the FDA for the use of their frozen Stem Cell inventory and ship the Adipose-Derived Stem Cells from their inventory. My friend’s internist appealed to the head of infectious disease at the suburban hospital where my friend was now on life support but time ran out last night at 8:00 pm as the COVID-19 virus destroyed his multiple organs. He had played his last softball game two months earlier and was looking forward to playing again this spring.

Stem Cells for COVID-19 Pneumonia

I have previously written, here in my Blog, about the use of Stem Cells for COVID-19 Pneumonia. Unlike bacterial pneumonia managed with antibiotics, COVID-19 Pneumonia lasts longer and causes more damage. It is described, “like multiple wildfires, leaving destroyed lung tissue in its wake,” according to an article appearing in Feinberg-Northwestern Medicine’s January 11 journal. “The target cells of COVID-19 pneumonia are the immune cells: macrophages and T-Cells. While these cells are typically charged with protecting the lung, the COVID-19 turns the immune system against the lung. Stem cells quiet the inflammatory response of immune cells, thus enabling initiation of the repair process in the injured lung.”

In the Blog to which I am alluding, there was a call to action, Store your Stem Cells. The early results concerning the use of Stem Cells in COVID-19 Pneumonia are very promising. I am able to perform a mini-liposuction as an outpatient procedure and can arrange to have your cells frozen in storage, just as the umbilical cord of a newborn is being placed in deep freeze in case of future stem cell need. In the meantime, keep a distance, wear a mask, and search for a vaccination opportunity. In the next several weeks, Walgreens and CVS will begin offering vaccination the 1B group starting with those over age 75.

To learn more, schedule an appointment by calling (847) 390-7666. You may learn more at my website:
www.SheinkopMD.com as well as at www.PersonalizedStemcells.com

Pin It on Pinterest

Share This